X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9417) 9417
Newsletter (70) 70
Magazine Article (23) 23
Book Chapter (9) 9
Newspaper Article (6) 6
Transcript (3) 3
Dissertation (2) 2
Publication (2) 2
Book Review (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8148) 8148
female (5283) 5283
male (5257) 5257
prednisolone - therapeutic use (3679) 3679
adult (3506) 3506
middle aged (3484) 3484
prednisolone - adverse effects (3006) 3006
prednisolone (2771) 2771
prednisolone - administration & dosage (2660) 2660
aged (2227) 2227
treatment outcome (1790) 1790
corticosteroids (1581) 1581
adolescent (1462) 1462
drug therapy, combination (1321) 1321
child (1148) 1148
glucocorticoids - therapeutic use (1021) 1021
therapy (993) 993
glucocorticoids - adverse effects (867) 867
anti-inflammatory agents - therapeutic use (824) 824
immunosuppressive agents - therapeutic use (811) 811
animals (775) 775
time factors (761) 761
glucocorticoids - administration & dosage (755) 755
retrospective studies (736) 736
steroids (707) 707
medicine, general & internal (701) 701
child, preschool (690) 690
immunosuppressive agents - adverse effects (681) 681
follow-up studies (665) 665
rheumatology (637) 637
care and treatment (626) 626
antineoplastic combined chemotherapy protocols - therapeutic use (609) 609
medicine & public health (606) 606
surgery (606) 606
administration, oral (595) 595
oncology (594) 594
transplantation (572) 572
children (557) 557
dose-response relationship, drug (554) 554
glucocorticoids (553) 553
drug administration schedule (545) 545
aged, 80 and over (541) 541
risk factors (540) 540
anti-inflammatory agents - administration & dosage (538) 538
anti-inflammatory agents - adverse effects (538) 538
prospective studies (534) 534
drug therapy (529) 529
antineoplastic combined chemotherapy protocols - adverse effects (523) 523
immunology (514) 514
pediatrics (503) 503
hematology (494) 494
recurrence (486) 486
pharmacology & pharmacy (463) 463
patients (457) 457
cyclophosphamide - administration & dosage (441) 441
arthritis, rheumatoid - drug therapy (440) 440
vincristine - administration & dosage (432) 432
ophthalmology (426) 426
infant (424) 424
chemotherapy (420) 420
remission induction (420) 420
young adult (415) 415
dermatology (414) 414
double-blind method (413) 413
azathioprine - therapeutic use (401) 401
management (399) 399
analysis (398) 398
gastroenterology & hepatology (395) 395
disease (392) 392
immunosuppressive agents - administration & dosage (392) 392
prognosis (390) 390
double-blind (385) 385
health aspects (369) 369
research (368) 368
urology & nephrology (354) 354
prednisolone - analogs & derivatives (347) 347
cyclophosphamide - adverse effects (346) 346
dosage and administration (346) 346
biopsy (345) 345
dexamethasone (338) 338
acute disease (334) 334
diagnosis (333) 333
kidney transplantation (332) 332
cyclophosphamide (328) 328
cancer (326) 326
cyclosporine - therapeutic use (320) 320
efficacy (316) 316
severity of illness index (313) 313
doxorubicin - administration & dosage (305) 305
asthma - drug therapy (304) 304
rheumatoid arthritis (304) 304
prednisolone - pharmacology (303) 303
inflammation (301) 301
rituximab (294) 294
cyclophosphamide - therapeutic use (290) 290
adrenal cortex hormones - therapeutic use (289) 289
cyclosporine (287) 287
adrenal cortex hormones - adverse effects (282) 282
prednisone (279) 279
clinical trials (274) 274
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8339) 8339
Japanese (511) 511
German (390) 390
Russian (248) 248
French (118) 118
Spanish (35) 35
Italian (29) 29
Danish (23) 23
Chinese (22) 22
Hungarian (22) 22
Dutch (12) 12
Portuguese (12) 12
Swedish (10) 10
Polish (8) 8
Ukrainian (7) 7
Bulgarian (5) 5
Norwegian (5) 5
Korean (4) 4
Turkish (4) 4
Czech (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Finnish (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
Seminars in arthritis and rheumatism, ISSN 0049-0172, 2017, Volume 46, Issue 6, pp. 819 - 827
Journal Article
British journal of haematology, ISSN 0007-1048, 2015, Volume 169, Issue 5, pp. 672 - 682
... (n = 24) were 33% (95% CI, 16–55%) and 75%, respectively. Grade ≥ 3 treatment‐emergent adverse events, including anaemia, thrombocytopenia, lymphopenia... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
Journal Article
British journal of haematology, ISSN 0007-1048, 2017, Volume 178, Issue 5, pp. 772 - 780
Summary We compared the efficacy and safety of gemcitabine, cisplatin, prednisone and thalidomide (GDPT) with standard CHOP regimen (cyclophosphamide,... 
GDPT | peripheral T‐cell lymphoma | chemotherapy | safety | efficacy | peripheral T-cell lymphoma | SURVIVAL | TRIAL | DEXAMETHASONE | NON-HODGKINS-LYMPHOMA | REGIMEN | THERAPIES | HEMATOLOGY | Prednisolone - adverse effects | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Young Adult | Lymphoma, T-Cell, Peripheral - metabolism | Biomarkers, Tumor - metabolism | Vincristine - administration & dosage | Adult | Deoxycytidine - adverse effects | Female | Gene Expression Regulation, Neoplastic - drug effects | Doxorubicin - administration & dosage | Thalidomide - adverse effects | Lymphoma, T-Cell, Peripheral - drug therapy | Prednisone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Deoxycytidine - administration & dosage | RNA, Messenger - genetics | Lymphoma, T-Cell, Peripheral - genetics | Treatment Outcome | Thalidomide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Cisplatin - adverse effects | RNA, Neoplasm - genetics | Vincristine - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Doxorubicin - adverse effects | Antimitotic agents | Care and treatment | Chemotherapy | Corticosteroids | Analysis | Prednisone | Non-Hodgkin's lymphomas | Antineoplastic agents | T cells | Biological markers | Steroids | Cancer | Therapy | Gemcitabine | Toxicity | Lymphocytes T | Gene expression | Survival | Patients | Doxorubicin | Vincristine | Lymphoma | Cisplatin | Cyclophosphamide | Biomarkers | ERCC1 protein | Remission | Lymphomas | Safety | Thalidomide | T-cell lymphoma | Acute toxicity | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 352 - 360
... increased overall survival, with a low rate of adverse effects. 
ANDROGEN-DEPRIVATION THERAPY | MEDICINE, GENERAL & INTERNAL | RECOMMENDATIONS | PLACEBO-CONTROLLED PHASE-3 | SURVIVAL ANALYSIS | CLINICAL-TRIALS | DOUBLE-BLIND | LEUPROLIDE ACETATE | DOCETAXEL | CHEMOTHERAPY | NEOADJUVANT | Prednisolone - adverse effects | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prostatic Neoplasms - radiotherapy | Prednisolone - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Abiraterone Acetate - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Prostatic Neoplasms - mortality | Abiraterone Acetate - administration & dosage | Neoplasm Metastasis - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Androgen Antagonists - therapeutic use | Adult | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Prostatic Neoplasms - drug therapy | Androgen suppression therapy | Usage | Prednisone | Research | Prostate cancer | Medical research | Prostate-specific antigen | Clinical trials | Metastasis | Patients | Cancer therapies | Metastases | Androgens | Chemotherapy | Pain | Castration | Medical prognosis | Hypokalemia | Death | Prostate | Abiraterone Acetate/administration & dosage | Prednisolone/administration & dosage | Androgen Antagonists/administration & dosage | Medical and Health Sciences | Medicin och hälsovetenskap | Neoplasm Metastasis/drug therapy | Steroid 17-alpha-Hydroxylase/antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Klinisk medicin | Clinical Medicine | Prostatic Neoplasms/drug therapy | Cancer and Oncology | Cancer och onkologi
Journal Article
Journal of the American Society of Nephrology, ISSN 1533-3450, 2018, Volume 29, Issue 1, pp. 317 - 325
Journal Article
Hematology, ISSN 1024-5332, 04/2007, Volume 12, Issue 2, pp. 141 - 147
We have evaluated the best method to assess the ovarian reserve and the ovarian protective effect of GnRH-analog (GnRH... 
INHIBIN-B | GNRH-A | FSH | AMH | POF | GnRH-a | Inhibin-B | GONADOTROPIN-RELEASING-HORMONE | inhibin-B | PREVENTION | CHILDHOOD | DAMAGE | CHEMOTHERAPY | FERTILITY | PRESERVATION | RESERVE | GnRH-alpha | LYMPHOMA | HEMATOLOGY | Procarbazine - administration & dosage | Predictive Value of Tests | Prednisolone - adverse effects | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Prednisolone - administration & dosage | Humans | Mechlorethamine - adverse effects | Dexamethasone - adverse effects | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Ovarian Follicle - diagnostic imaging | Time Factors | Anti-Mullerian Hormone | Follicle Stimulating Hormone - blood | Vincristine - administration & dosage | Hodgkin Disease - physiopathology | Amenorrhea - chemically induced | Amenorrhea - physiopathology | Dacarbazine - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Combined Modality Therapy | Glycoproteins - blood | Testicular Hormones - blood | Bleomycin - administration & dosage | Infertility, Female - blood | Cytarabine - administration & dosage | Primary Ovarian Insufficiency - blood | Primary Ovarian Insufficiency - chemically induced | Infertility, Female - pathology | Infertility, Female - physiopathology | Procarbazine - adverse effects | Adolescent | Vincristine - adverse effects | Infertility, Female - prevention & control | Primary Ovarian Insufficiency - physiopathology | Primary Ovarian Insufficiency - prevention & control | Ovary - physiopathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Vinblastine - adverse effects | Sensitivity and Specificity | Ultrasonography | Hodgkin Disease - drug therapy | Infertility, Female - chemically induced | Adult | Female | Inhibins - blood | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Amenorrhea - blood | Luteinizing Hormone - blood | Survivors | Bleomycin - adverse effects | Triptorelin Pamoate - therapeutic use | Amenorrhea - prevention & control | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Mechlorethamine - administration & dosage | Doxorubicin - adverse effects
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESPONSE CRITERIA | AGGRESSIVE LYMPHOMAS | POOR-PROGNOSIS | NON-HODGKINS-LYMPHOMA | REGIMEN | YOUNG-PATIENTS | ELDERLY-PATIENTS | DES-LYMPHOMES | TRANSPLANTATION | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Evidence-based medicine | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article